Get the Stockscreener App
67.29
1.25%
0.83
After Hours:
67.30
0.010
+0.01%
Dexcom Inc stock is traded at $67.29, with a volume of 3.76M.
It is up +1.25% in the last 24 hours and down -10.68% over the past month.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
See More
Previous Close:
$66.46
Open:
$66.7
24h Volume:
3.76M
Relative Volume:
0.84
Market Cap:
$26.39B
Revenue:
$4.30B
Net Income/Loss:
$571.50M
P/E Ratio:
46.73
EPS:
1.44
Net Cash Flow:
$570.80M
1W Performance:
-1.33%
1M Performance:
-10.68%
6M Performance:
-0.66%
1Y Performance:
+0.37%
1-Day Range:
$66.18
$67.61
1-Week Range:
$65.18
$70.18
52-Week Range:
$57.52
$93.25
Dexcom Inc Stock (DXCM) Company Profile
Name
Dexcom Inc
Sector
Industry
Phone
(858) 200-0200
Address
6340 SEQUENCE DRIVE, SAN DIEGO, CA
Compare DXCM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DXCM
Dexcom Inc
|
67.29 | 26.06B | 4.30B | 571.50M | 570.80M | 1.44 |
|
ABT
Abbott Laboratories
|
133.94 | 231.67B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
97.63 | 143.79B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
369.67 | 141.41B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
95.24 | 120.53B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
77.77 | 45.32B | 5.69B | 1.41B | 577.90M | 6.95 |
Dexcom Inc Stock (DXCM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-08-25 | Downgrade | Oppenheimer | Outperform → Perform |
| Aug-21-25 | Initiated | Argus | Buy |
| Jun-16-25 | Initiated | Truist | Buy |
| May-30-25 | Initiated | Goldman | Buy |
| Apr-10-25 | Initiated | Mizuho | Outperform |
| Feb-03-25 | Upgrade | Redburn Atlantic | Neutral → Buy |
| Jan-16-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jul-26-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-26-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-30-24 | Initiated | Redburn Atlantic | Neutral |
| Mar-12-24 | Initiated | RBC Capital Mkts | Outperform |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| Apr-17-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Mar-29-23 | Initiated | UBS | Buy |
| Jan-26-23 | Initiated | Wolfe Research | Outperform |
| Oct-18-22 | Initiated | Barclays | Equal Weight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-15-22 | Initiated | Bernstein | Outperform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-03-22 | Upgrade | BTIG Research | Neutral → Buy |
| Jan-19-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-07-22 | Upgrade | Guggenheim | Neutral → Buy |
| Oct-18-21 | Downgrade | Guggenheim | Buy → Neutral |
| Jul-21-21 | Resumed | Cowen | Outperform |
| May-28-21 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-15-21 | Initiated | Atlantic Equities | Overweight |
| Jan-06-21 | Upgrade | UBS | Neutral → Buy |
| Oct-02-20 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| May-27-20 | Reiterated | Piper Sandler | Overweight |
| May-14-20 | Initiated | Wells Fargo | Equal Weight |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Nov-07-19 | Reiterated | Canaccord Genuity | Buy |
| Nov-07-19 | Upgrade | Guggenheim | Neutral → Buy |
| Oct-23-19 | Initiated | Stifel | Buy |
| Nov-28-18 | Initiated | UBS | Neutral |
| Oct-19-18 | Upgrade | Goldman | Sell → Neutral |
| Sep-12-18 | Upgrade | Northland Capital | Under Perform → Market Perform |
| Aug-02-18 | Reiterated | Canaccord Genuity | Buy |
| Jul-02-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jun-08-18 | Upgrade | JP Morgan | Neutral → Overweight |
| May-11-18 | Initiated | BofA/Merrill | Buy |
| May-03-18 | Reiterated | Canaccord Genuity | Buy |
| Apr-04-18 | Initiated | Goldman | Sell |
| Apr-04-18 | Initiated | Guggenheim | Neutral |
| Mar-23-18 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jan-04-18 | Downgrade | Northland Capital | Market Perform → Under Perform |
| Sep-28-17 | Reiterated | Wedbush | Outperform |
View All
Dexcom Inc Stock (DXCM) Latest News
DexCom (DXCM) Maintains Buy Rating with Price Target Unchanged a - GuruFocus
Can DexCom Inc. stock deliver sustainable ROEWeekly Profit Analysis & Free Weekly Chart Analysis and Trade Guides - newser.com
DexCom (NASDAQ:DXCM) Earns Buy Rating from Canaccord Genuity Group - MarketBeat
Will Rising Costs Hurt Garodia Chemicals Limiteds Margins This YearEarnings Per Share Trends & Free Long-Term Investment Planning - earlytimes.in
SWS Partners Makes New Investment in DexCom, Inc. $DXCM - MarketBeat
What drives DexCom Inc stock priceStock Buyback Updates & Our Experts Decode Market Noise for You - earlytimes.in
Is DexCom Inc a good long term investmentEarnings Call Summaries & Exceptional Profit Ideas - earlytimes.in
UBS Downplays G7 CGM Sensor Concerns, Affirms DexCom’s Inc. (DXCM) ‘Buy’ Rating - Yahoo Finance
What dividend safety rating applies to DexCom Inc. (DC4) stockEarnings Miss & Consistent Profit Trading Strategies - newser.com
DexCom CEO takes medical leave - MSN
Is DexCom Inc. (DC4) stock resilient in recession scenariosQuarterly Investment Review & Real-Time Buy Zone Alerts - newser.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DexCom, Inc.DXCM - WV News
What drives DexCom Inc DC4 stock priceEarnings Beat Highlights & Free Stock Price Trend Analysis - earlytimes.in
Fifth Third Bancorp Sells 7,380 Shares of DexCom, Inc. $DXCM - MarketBeat
DexCom Inc Stock Analysis and ForecastEarnings Per Share Trends & Double Digit Profit Strategies - earlytimes.in
User - FinancialContent
DexCom (DXCM) Target Price Lowered by Baird Analyst Jeff Johnson - GuruFocus
Robert W. Baird Has Lowered Expectations for DexCom (NASDAQ:DXCM) Stock Price - MarketBeat
Baird Adjusts Price Target on DexCom to $90 From $112, Maintains Outperform Rating - MarketScreener
Congress Asset Management Co. Sells 107,637 Shares of DexCom, Inc. $DXCM - MarketBeat
Banque Pictet & Cie SA Has $7.78 Million Stake in DexCom, Inc. $DXCM - MarketBeat
Global Wearable Medical Devices Market is Predicted to Reach USD 185 Billion by 2032 | DelveInsight - GlobeNewswire Inc.
Beacon Investment Advisory Services Inc. Sells 146,154 Shares of DexCom, Inc. $DXCM - MarketBeat
CHICAGO TRUST Co NA Decreases Position in DexCom, Inc. $DXCM - MarketBeat
1 Growth Stock Down 40% to Buy Hand Over Fist Right Now - AOL.com
DexCom, Inc. Experiences Revision in Stock Evaluation Amid Market Volatility - Markets Mojo
DexCom Stock Forms Death Cross, Signaling Potential Bearish Trend Ahead - Markets Mojo
Compagnie Lombard Odier SCmA Buys 53,092 Shares of DexCom, Inc. $DXCM - MarketBeat
Covea Finance Purchases 27,300 Shares of DexCom, Inc. $DXCM - MarketBeat
Mn Services Vermogensbeheer B.V. Purchases 6,800 Shares of DexCom, Inc. $DXCM - MarketBeat
DexCom comes under fire from accusations - MarketScreener
TCV Trust & Wealth Management Inc. Invests $434,000 in DexCom, Inc. $DXCM - MarketBeat
DexCom Stock Hits Day Low of $66.90 Amid Price Pressure - Markets Mojo
DexCom (NASDAQ:DXCM) Shares Gap DownHere's What Happened - MarketBeat
Baader Bank Aktiengesellschaft Makes New Investment in DexCom, Inc. $DXCM - MarketBeat
DexCom, Inc. Securities Lawsuit Investigation - Claim Depot
DexCom is under fire from accusations - MarketScreener
DexCom stock rating defended by UBS amid G7 sensor concerns - Investing.com
Czech National Bank Acquires 6,108 Shares of DexCom, Inc. $DXCM - MarketBeat
Financiere des Professionnels Fonds d investissement inc. Takes $1.43 Million Position in DexCom, Inc. $DXCM - MarketBeat
Atle Fund Management AB Has $4.44 Million Holdings in DexCom, Inc. $DXCM - MarketBeat
Bowman & Co S.C. Increases Position in DexCom, Inc. $DXCM - MarketBeat
Assenagon Asset Management S.A. Has $105.47 Million Stock Holdings in DexCom, Inc. $DXCM - MarketBeat
IFM Investors Pty Ltd Buys 7,619 Shares of DexCom, Inc. $DXCM - MarketBeat
Swedbank AB Boosts Stake in DexCom, Inc. $DXCM - MarketBeat
Dexcom Inc Stock (DXCM) Financials Data
Revenue
Net Income
Cash Flow
EPS
Dexcom Inc Stock (DXCM) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Stern Sadie | EVP, Chief HR Officer |
Sep 04 '25 |
Sale |
80.00 |
1,466 |
117,280 |
105,223 |
1.30%
0.61%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):